Randomised controlled tiral (RCT) detail
| Studies | |
| Number of RCTs | 127/147 (86.4) |
| Number of pilot studies | 13/147 (8.8) |
| Number of RCT protocols | 7/147 (4.8) |
| World region for recruitment | |
| Asia | 54/147 (36.7) |
| North America | 36/147 (24.5) |
| Europe | 26/147 (17.7) |
| Africa | 15/147 (8.5) |
| Latin America | 1/147 (0.7) |
| Australasia | 15/147 (8.5) |
| Year published | |
| 2012 | 26/147 (17.8) |
| 2013 | 24/147 (16.3) |
| 2014 | 24/147 (16.3) |
| 2015 | 33/147 (22.4) |
| 2016 | 40/147 (27.2) |
| Number of sites | |
| 1 | 132/147 (89.8) |
| 2–3 | 9/147 (6.1) |
| 4–5 | 2/147 (1.4) |
| >5 | 4/147 (2.7) |
| Number of participants in full RCTs | |
| <10 | 4/127 (3.1) |
| 11–50 | 62/127 (48.8) |
| 51–100 | 39/127 (30.7) |
| 101–150 | 11/127 (8.7) |
| >150 | 11/127 (8.7) |
| Participants recruited | |
| <18 years | 24/147 (16.3) |
| >18 years | 59/147 (40.1) |
| Mixed age range | 25/147 (17.0) |
| Not stated | 34/147 (23.1) |
| N/A (protocol)‡ | 5/147 (3.4) |
| Type of intervention | |
| Dressings and wound care | 38/147 (25.9) |
| Surgical technique | 19/147 (12.9) |
| Treatment of pain or itch* | 16/147 (10.9) |
| Impact of exercise and rehabilitation | 13/147 (8.8) |
| Intensive care management | 10/147 (6.8) |
| Treatment of hypermetabolism | 8/147 (5.4) |
| Nutrition | 8/147 (5.4) |
| Scar management | 7/147 (4.8) |
| Treatment of inhalational injury | 3/147 (2.0) |
| Use of topical rHGM | 3/147 (2.0) |
| Use of rHGH | 3/147 (2.0) |
| Sugar management | 2/148 (2.0) |
| Treatment of infection | 2/147 (1.4) |
| Treatment of DVT | 2/147 (1.4) |
| Blood management | 2/147 (1.4) |
| Extracorporeal shock wave therapy | 2/147 (1.4) |
| Platelet-rich plasma use | 2/147 (1.4) |
| Others† | 7/147 (5.4) |
*Inc. distraction for dressing changes.
†Inc. levamisole, hyperbaric oxygen, fibroblast growth factor, oral calcium use, ketoconazole, low intensity laser.
‡No participants reported as study is a protocol.
DVT, deep vein thrombosis; N/A, not applicable; rHGH, recombinant human growth hormone; rHGM, recombinant Human Granulocyte-Macrophage colony-stimulating factor.